SCHEMBL23892186

SCHEMBL23892186

Cc1cccc(CN(CC(=O)NO)Cc2cccc(C(=O)O)c2)c1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MEP1B Q16820 20/20 0.85
▸ MEP1A Q16819 4/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19474736 0.92 MEP1B (1.00) MEP1BMEP1A
SCHEMBL31260504 0.91 MEP1B (1.00) MEP1BMEP1A
SCHEMBL19512593 0.91 MEP1B (1.00) MEP1BMEP1A
SCHEMBL31260551 0.89 MEP1B (1.00) MEP1BMEP1A
SCHEMBL19474709 0.89 MEP1B (1.00) MEP1BMEP1A
SCHEMBL23892162 0.89 MEP1B (0.85) MEP1BMEP1A
SCHEMBL29417394 0.87 MEP1B (1.00) MEP1BMEP1A
SCHEMBL19478225 0.87 MEP1B (1.00) MEP1BMEP1A
SCHEMBL31260513 0.86 MEP1B (0.82) MEP1BMEP1A
SCHEMBL19510227 0.86 MEP1B (0.82) MEP1BMEP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3445744-B1 NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA VIVORYON THERAPEUTICS AG (DE) 2021-10-06 — — EP disclosed
Send feedback